OrsoBio
Biotechnology Research
Palo Alto, California, United States
19 employees
- Employees
- 19
- Contacts
- 4
- Emails
- 4
- Phones
- 1
OrsoBio Overview
- Headquarters
- Palo Alto, California, United States
- Website
- www.orsobio.com
- Industry
- Biotechnology Research
- Employees
- 19
- Founded
- 2021
- Funding
- 67.0M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About OrsoBio
OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. OrsoBio currently has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism.
OrsoBio Contact Details
- People in AeroLeads
- 4
- With contact data
- 4
- Email contacts
- 4
- 100.0% coverage
- Phone contacts
- 1
- 25.0% coverage
OrsoBio Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Jane S. | Senior Director, Regulatory Affairs | San Francisco Bay Area, United States |
Email
|
| Steve Weng | San Francisco Bay Area, United States |
Email
Phone
|
|
| Gans Ganapati | Co-founder, Cbo/cfo @ Orsobio | Palo Alto, California, United States |
Email
|
| Eisuke Murakami | VP of Dmpk and Translational Research | San Mateo, California, United States |
Email
|
Employees by Management Level
Executive
1 profile
VP / Head
1 profile
Director
1 profile
Compare Similar Companies to OrsoBio
Vaxcyte
Biotechnology Research
Arsenal Biosciences, Inc.
Biotechnology Research
Terremoto Biosciences
Biotechnology Research
Circle Pharma, Inc.
Biotechnology Research
GC Therapeutics
Biotechnology Research
Athira Pharma
Biotechnology
Gate Bioscience
Biotechnology Research
Nura Bio
Biotechnology
858 Therapeutics
Biotechnology Research
Hoth Therapeutics, Inc
Biotechnology